DJANINN GENDRON: Open Payments
NPI 1023422805 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 9 payments from 3 companies in 2025. Trend: 2023 $153 · 2024 $293 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 6 | $121 |
| Alkermes, Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: INGREZZA, ARISTADA, LYBALVI.
Industry payments across ND — which companies pay providers there.
